Tech Company Financing Transactions
Dren Bio Funding Round
Dren Bio secured a $60 million Series A financing round on 10/19/2020. Backers included SR One Capital Management, Taiho Ventures and 8VC.
Transaction Overview
Company Name
Announced On
10/19/2020
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series A
Investors
SR One Capital Management (Lead Investor)
Taiho Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
733 Industrial Rd.
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
Dren Bio is a biotechnology company developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren's lead programs are initially focused on hematologic neoplasms and solid cancers. Dren is actively working in other areas including auto-immune disorders and diseases of protein aggregation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nenad Tomasevic
Chief Financial Officer
John Wesley
Browse more venture capital transactions:
Prev: 10/16/2020: Alpaca venture capital transaction
Next: 10/19/2020: Future venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs